In Failing Hearts, Cardiomyocytes Alter Metabolism

While the heart cells normally burn fatty acids, when things go wrong ketones become the preferred fuel source.

Written byAmanda B. Keener
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CHANGE-UP: Healthy cardiomyocytes (left panel) mainly use fatty acids as their energy source. But in a mouse model of heart failure and in failing human hearts (right panel), cardiomyocytes depend more on ketones for energy.
See full infographic: WEB
THE SCIENTIST STAFF

The paper
G. Aubert et al., “The failing heart relies on ketone bodies as a fuel,” Circulation, 133:698-705, 2016.

As organs go, the heart is an energy hog. To keep it fueled, mitochondria within cardiomyocytes (heart muscle cells) constantly churn out ATP as a product of the citric acid cycle. In the heart, most of the cycle’s substrates come from the metabolism of fatty acids, but the organ can also make use of other compounds such as lactate or ketones.

When Daniel Kelly of Sanford Burnham Prebys Medical Discovery Institute in Orlando, Florida, learned that some rare genetic disorders both cause dysfunction of the heart muscle and simultaneously disrupt fatty acid oxidation and increase ketone metabolism, he wondered if ketones might play a role in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

June 2016

Found in Translation

Some supposedly nonfunctional RNA molecules encode functional peptides

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies